Literature DB >> 1748666

Molecular characterization of a mammalian smooth muscle myosin light chain kinase.

P J Gallagher1, B P Herring, S A Griffin, J T Stull.   

Abstract

A 5.6-kilobase cDNA clone has been isolated which includes the entire coding region for the myosin light chain kinase from rabbit uterine tissue. This cDNA, expressed in COS cells, encodes a Ca2+/calmodulin-dependent protein kinase with catalytic properties similar to other purified smooth muscle myosin light chain kinases. A module (TLKPVGNIKPAE), repeated sequentially 15 times, has been identified near the N terminus of this smooth muscle kinase. It is not present in chicken gizzard or rabbit skeletal muscle myosin light chain kinases. This repeat module and a subrepeat (K P A/V) are similar in amino acid content to repeated motifs present in other proteins, some of which have been shown to associate with chromatin structures. Immunoblot analysis after sodium dodecyl sulfate-polyacrylamide gel electrophoresis, used to compare myosin light chain kinase present in rabbit, bovine, and chicken smooth and nonmuscle tissues, showed that within each species both tissue types have myosin light chain kinases with indistinguishable molecular masses. These data suggest that myosin light chain kinases present in smooth and nonmuscle tissues are the same protein.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1748666      PMCID: PMC2836767     

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  59 in total

Review 1.  Prediction of the secondary structure of proteins from their amino acid sequence.

Authors:  P Y Chou; G D Fasman
Journal:  Adv Enzymol Relat Areas Mol Biol       Date:  1978

2.  The interaction in vitro of the intermediate filament protein vimentin with naturally occurring RNAs and DNAs.

Authors:  P Traub; W J Nelson; S Kühn; C E Vorgias
Journal:  J Biol Chem       Date:  1983-02-10       Impact factor: 5.157

3.  Purification and characterization of smooth muscle myosin light chain kinase.

Authors:  R S Adelstein; C B Klee
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

4.  Activation of skeletal muscle myosin light chain kinase by calcium(2+) and calmodulin.

Authors:  D K Blumenthal; J T Stull
Journal:  Biochemistry       Date:  1980-11-25       Impact factor: 3.162

5.  Effects of pH, ionic strength, and temperature on activation by calmodulin an catalytic activity of myosin light chain kinase.

Authors:  D K Blumenthal; J T Stull
Journal:  Biochemistry       Date:  1982-05-11       Impact factor: 3.162

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Human platelet myosin light chain kinase requires the calcium-binding protein calmodulin for activity.

Authors:  D R Hathaway; R S Adelstein
Journal:  Proc Natl Acad Sci U S A       Date:  1979-04       Impact factor: 11.205

8.  Calcium-sensitive regulation of actin-myosin interactions in baby hamster kidney (BHK-21) cells.

Authors:  M J Yerna; R Dabrowska; D J Hartshorne; R D Goldman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

9.  Partial purification and characterization of myosin light chain kinase from bovine thyroid gland.

Authors:  M Tawata; R Kobayashi; J B Field
Journal:  Endocrinology       Date:  1983-02       Impact factor: 4.736

10.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

View more
  51 in total

1.  Targeted expression of SV40 large T-antigen to visceral smooth muscle induces proliferation of contractile smooth muscle cells and results in megacolon.

Authors:  B P Herring; A M Hoggatt; A F Smith; P J Gallagher
Journal:  J Biol Chem       Date:  1999-06-18       Impact factor: 5.157

2.  Localization of an actin binding domain in smooth muscle myosin light chain kinase.

Authors:  P J Gallagher; J T Stull
Journal:  Mol Cell Biochem       Date:  1997-08       Impact factor: 3.396

3.  Smooth muscle myosin light chain kinase expression in cardiac and skeletal muscle.

Authors:  B P Herring; S Dixon; P J Gallagher
Journal:  Am J Physiol Cell Physiol       Date:  2000-11       Impact factor: 4.249

4.  Biochemical properties of chimeric skeletal and smooth muscle myosin light chain kinases.

Authors:  S A Leachman; P J Gallagher; B P Herring; M J McPhaul; J T Stull
Journal:  J Biol Chem       Date:  1992-03-05       Impact factor: 5.157

Review 5.  Vascular smooth muscle phenotypic diversity and function.

Authors:  Steven A Fisher
Journal:  Physiol Genomics       Date:  2010-08-24       Impact factor: 3.107

Review 6.  Myosin light chain kinase in microvascular endothelial barrier function.

Authors:  Qiang Shen; Robert R Rigor; Christopher D Pivetti; Mack H Wu; Sarah Y Yuan
Journal:  Cardiovasc Res       Date:  2010-05-17       Impact factor: 10.787

7.  Smooth muscle myosin light chain kinase is transiently expressed in skeletal muscle during embryogenesis and muscle regeneration both in vivo and in vitro.

Authors:  L Dalla Libera; M Podhorska-Okolow; B Martin; M L Massimino; R Brugnolo; M Cantini
Journal:  J Muscle Res Cell Motil       Date:  1997-06       Impact factor: 2.698

Review 8.  Myosin light chain kinases.

Authors:  P J Gallagher; B P Herring; J T Stull
Journal:  J Muscle Res Cell Motil       Date:  1997-02       Impact factor: 2.698

9.  Wortmannin binds specifically to 1-phosphatidylinositol 3-kinase while inhibiting guanine nucleotide-binding protein-coupled receptor signaling in neutrophil leukocytes.

Authors:  M Thelen; M P Wymann; H Langen
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-24       Impact factor: 11.205

10.  Arrest defective-1 controls tumor cell behavior by acetylating myosin light chain kinase.

Authors:  Dong Hoon Shin; Yang-Sook Chun; Kyoung-Hwa Lee; Hyun-Woo Shin; Jong-Wan Park
Journal:  PLoS One       Date:  2009-10-14       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.